Printer Friendly

Guangji Pharma Planning to Establish Vitamin B6 Production JV.

28 October 2009 - Hubei Guangji Pharmaceutical Co. Ltd. is planning to establish a joint venture facility with Xianning Jinghui Pharmaceutical Co. Ltd. and Wuhan Hexie Pharmaceutical Co. Ltd. to produce vitamin B6, announced Guangji Pharma today.

The construction of the facility is expected to last 18 months. With a total investment of RMB 102.8 million (about USD 15 million), the plant is expected to have a yearly capacity of 1,000 tons and should achieve annual sales of RMB 124 million when fully operational.

The new joint venture for the vitamin B6 project is named Hubei Guanghui Pharmaceutical Co. Ltd with a capital registration of RMB 50 million, 50% from Guangji Pharma; 40% Xianning Jinghui and 10% Hexie Pharma.

Hubei Guangji Pharmaceutical Co. Ltd. has stated that this joint venture has not yet been formally established and is subject to their final approval.
COPYRIGHT 2009 Global Data Systems
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Feedinfo News Service
Date:Oct 28, 2009
Words:144
Previous Article:Philippines - Monterey Foods Corporation Merges With Livestock Firm.
Next Article:Feed-Grade Skim Milk Powder and Whey Production in Selected Countries -- August/September 2009.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters